Axel Bolte

Companies

• Inozyme Pharma, Inc.Board member Jul 23, 2020 to now¹
• IVERIC bioBoard member Sep 24, 2013 to Jul 13, 2023²
• Inozyme Pharma, Inc.Chief executive officer Jan 14, 2021 to Oct 4, 2022³
• Inozyme Pharma, Inc.Officer Jul 23, 2020 to Jul 24, 2020¹
• Allena Pharmaceuticals, Inc.Board member Nov 1, 2017 to Jun 12, 2018⁴
• Nabriva Therapeutics plcBoard member Dec 30, 2016 to Dec 30, 2016⁵
• PTC TherapeuticsBoard member Jun 19, 2013 to Jun 27, 2013⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• IBIVERIC bio0 shares⁷Jul 11, 2023
• IPInozyme Pharma, Inc.0 shares⁸Jul 1, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 1, 2025U 423,926 shares at $4.00 of Inozyme Pharma, Inc.⁸
• May 15, 2025Exercised options 4,407 shares at $0.98 of Inozyme Pharma, Inc.⁹
• May 15, 2025Exercised options 152,823 shares at $0.98 of Inozyme Pharma, Inc.⁹
• Jul 11, 2023Returned to company 22,088 shares of IVERIC bio⁷
• May 11, 2023Exercised options 14,588 shares of IVERIC bio¹⁰
• Mar 31, 2023Granted 4,806 shares at $2.21 of Inozyme Pharma, Inc.¹¹
• Sep 30, 2022Granted 3,315 shares at $2.28 of Inozyme Pharma, Inc.¹²
• May 11, 2022Exercised options 7,500 shares of IVERIC bio¹³
• Apr 19, 2022Bought 67,750 shares at $3.69 of Inozyme Pharma, Inc.¹⁴